Results 201 to 210 of about 62,247 (257)

Standardization of postoperative adverse event reporting: A critical opportunity for improvement within the National Clinical Trials Network

Cancer, Volume 132, Issue 15, 1 August 2026.
Beth Helmink, Matthew H. G. Katz, Chandrajit P. Raut, Sumithra J. Mandrekar, Kristina Laumann, Allison Booth, Laura Hoffman, Eric A. Singer, Isabelle Bedrosian, Rebecca A. Snyder   +9 more
wiley   +1 more source

Molecular Characterization of Ovarian Yolk Sac Tumor in a Postmenopausal Woman: Implications for Pathogenesis

Journal of Obstetrics and Gynaecology Research, Volume 52, Issue 8, August 2026.
ABSTRACT Ovarian yolk sac tumor is a rare malignant germ cell tumor that typically occurs in young women. In postmenopausal women, yolk sac tumors are extremely rare and have a poor prognosis. These tumors may arise from different biological mechanisms, as germ cells are absent in postmenopausal ovaries.
Mihiro Dejima, Minoru Nagashima, Mamiko Onuki, Miki Kushima, Akihiko Sekizawa, Koji Matsumoto   +5 more
wiley   +1 more source

POSTN⁺ CAFs facilitate gastric cancer peritoneal metastasis by promoting ICAM-1-dependent tumor cell adhesion and CD8⁺ T-cell exhaustion. [PDF]

Front Immunol
Liu X, Yao Q, Wang Z, Wang P, Zhang Z, Shen Z, Li S, Yan Y, Fu W.   +8 more
europepmc   +1 more source

Predictors of Peritoneal Surface Recurrence and Quantitative Association with Time to Relapse After Complete CRS/HIPEC for Colorectal Peritoneal Metastasis. [PDF]

Cancers (Basel)
Hounschell CA, Swilling AC, Mirza S, Sanner-Dixon K, Haley J, Selby LV, Umar S, Al-Kasspooles M.   +7 more
europepmc   +1 more source

Real‐world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study

Cancer, Volume 132, Issue 14, 15 July 2026.
ABSTRACT Background Chemotherapy schemes have historically shown low efficacy in patients with metastatic melanoma and have been replaced by immunotherapy and targeted therapy. This work aimed to study whether chemotherapy remains an option after progression to immunotherapy in specific contexts.
Miguel‐Ángel Berciano‐Guerrero, Elisabeth Pérez‐Ruiz, Ainara Soria, Javier Medina Martínez, Pablo Ayala de Miguel, Eva Muñoz‐Couselo, Lorena Bellido, Rafael López Castro, Enrique Espinosa, Lourdes Gutiérrez Sanz, Pablo Cerezuela‐Fuentes, Almudena García Castaño, Guillermo Crespo, Teresa Puértolas, Carlos Aguado de la Rosa, Mónica Corral Subias, Begoña Campos Balea, Aida Bujosa Rodríguez, Victor Navarro Pérez, María José Lecumberri, Francisco Ramón García Arroyo, Alberto Jacobo Cunquero Tomás, Karmele Mujika, Luis Antonio Fernández, José Carlos Villa Guzmán, Berta Hernández, Joaquín Fra Rodríguez, José Luis Manzano, Salvador Martín Algarra, Iván Márquez‐Rodas   +29 more
wiley   +1 more source

Potential of Platelet-Based Drug Delivery System for Treating Peritoneal Metastasis of Gastric Cancer. [PDF]

Cancer Sci
Nakayama T, Shoda K, Higuchi Y, Ozawa T, Tanaka H, Saito R, Maruyama S, Takiguchi K, Izumo W, Furuya S, Shiraishi K, Kawaguchi Y, Amemiya H, Kawaida H, Yoshimura K, Tsukiji N, Suzuki-Inoue K, Ichikawa D.   +17 more
europepmc   +1 more source

The impact of time‐to‐recurrence on post‐recurrence mortality in stage I–III colorectal cancer: A nationwide Danish cohort study

International Journal of Cancer, Volume 159, Issue 2, Page 378-388, 15 July 2026.
What's new? Colorectal cancer (CRC) recurrence is a significant threat to survival despite surgery with curative intent. The characteristics of CRC recurrence, however, remain poorly understood, challenging postoperative surveillance. This study investigated post‐recurrence mortality and associations between time‐to‐recurrence and mortality among stage
Jesper Nors, Kåre Andersson Gotschalck, Rune Erichsen, Claus Lindbjerg Andersen   +3 more
wiley   +1 more source

Peritoneal metastasis of high-grade glioma via Ventriculoperitoneal shunt. [PDF]

Oxf Med Case Reports
Hamza HT, Sulaiman HS, Jaafar MG, Shengola SS, Saeed BJ, Omar SS, Fatah FM, Rasul KI, Surchi SA, Kakasur FA, Gheni MN, Mustafa CA.   +11 more
europepmc   +1 more source

Construction of competing-risk nomograms and identification of optimal candidates for aggressive therapy in gastric cancer with peritoneal metastasis: a population-based study. [PDF]

Transl Cancer Res
Zhang Z, Lu C, Wang W, Yang J, Tan Z.
europepmc   +1 more source

Radiomics-based machine learning in the prediction of peritoneal metastasis in ovarian cancer: a systematic review and meta-analysis. [PDF]

BMC Med Imaging
Salimi M, Vadipour P, Abdolizadeh A, Fayedeh F, Seifi S.   +4 more
europepmc   +1 more source